Catalyst Wire Dossier Catalyst Wire Dossier

MK0431A

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0431A, covering 2010-03-15 to 2011-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED) [Phase 3]

See pricing